Top compounds associated with response to SERHL2


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan FIMM pan-cancer AAC -0.001 1
mRNA Doxorubicin gCSI pan-cancer AAC -0.00035 1
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.00025 1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -5e-05 1
mRNA Bexarotene CTRPv2 pan-cancer AAC 2.7e-05 1
mRNA CH5424802 GDSC1000 pan-cancer AAC -1.3e-05 1
Download CSV